Skyrizi 180 MG/1.2 ML on-body 1.2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3SYZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,934
Award facts
- Contract value 100% obligated
- $24,934.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,934 delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 6, 2026, for the supply of SKYRIZI 180 mg/1.2 ml on-body injectors, with final delivery required by January 28, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under Amerisourcebergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999, which serves as the primary vehicle for supplying pharmaceutical products and medical commodities to support military healthcare systems globally through December 2026.
SKYRIZI (risankizumab), a biologic medication used primarily for the treatment of moderate-to-severe plaque psoriasis and other inflammatory conditions, represents part of DLA's ongoing pharmaceutical procurement to support military treatment facilities and related federal healthcare programs. Amerisourcebergen's role as a major pharmaceutical distributor positions it to efficiently fulfill the government's requirements for specialty medications across multiple therapeutic domains. The firm fixed-price structure and short performance timeline reflect the routine operational nature of delivery orders issued against the larger IDC vehicle, which enables flexible and responsive medical supply chain management across the Department of Defense healthcare enterprise.
Quick answers
Who was awarded contract SPE2DR26F3SYZ?
SPE2DR26F3SYZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F3SYZ worth?
The government has obligated $24,934 on SPE2DR26F3SYZ.
Is contract SPE2DR26F3SYZ an order under another contract?
Yes. SPE2DR26F3SYZ is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3SYZ competed?
The extent of competition for SPE2DR26F3SYZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award